Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.32 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anebulo Pharmaceuticals (ANEB) Other Accumulated Expenses (2022 - 2023)

Updated

Anebulo Pharmaceuticals (ANEB) posted Other Accumulated Expenses of $30,750 for fiscal Q3 2023 (quarter ended Mar 31, 2023), unchanged from the prior quarter.

Analysis

Anebulo Pharmaceuticals (ANEB) Other Accumulated Expenses (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Anebulo Pharmaceuticals 13.15 Mn 13.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 30,750.00
Dec 31, 2022 30,750.00
Sep 30, 2022 5,116.00
API Access

Anebulo Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ANEB&period=max&api_key=YOUR_API_KEY